Methods for analysis of biologically functional antibodies to the HIV-1 gp120 principal neutralizing domain.
The humoral response to HIV-1 infection has been demonstrated by a variety of immunoassays utilizing viral proteins. While several assays detect HIV-1 infection with high sensitivity and great specificity, little progress has been made to develop immunoassays correlative with disease progression and viral transmission. Antibodies toward the V3 domain of HIV-1 envelope can prevent virus infection and block virus-mediated cell fusion in vitro. Such properties may be critical to the course of the disease. Furthermore, understanding the role of neutralizing antibodies against HIV-1 during infection in humans and generating biologically relevant neutralizing antibodies are paramount to developing an efficacious AIDS vaccine. In this study we explored peptide binding and neutralization assays and their relation to predicting disease progression and viral transmission. Biologically relevant polyclonal and monoclonal neutralizing antibodies that were derived from natural HIV-1 infection of humans, experimental infections of chimpanzees, and viral envelope protein peptide immunizations were characterized. Comparison of V3-specific monoclonal antibodies by antigen-limited ELISA and a quantitative HIV-1 neutralization assay demonstrated a less than optimal predictive relationship between binding and neutralization potency. On the other hand, polyclonal sera from goats immunized with V3-specific peptides derived from three different HIV-1 strains, as well as sera from other HIV-1-infected individuals demonstrated correlation between binding affinity and neutralization.
Devash
Y
Y
Ortho Diagnostic Systems Inc., Raritan, New Jersey 08869.
Rusche
J R
JR
Nara
P L
PL
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D005260:Female; D015483:HIV Antibodies; D015488:HIV Antigens / Q000737:chemistry; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology / Q000635:transmission; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008431:Maternal-Fetal Exchange; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D002679:Pan troglodytes; D010455:Peptides / Q000737:chemistry / Q000276:immunology; D011247:Pregnancy
D000911:Antibodies, Monoclonal; D015483:HIV Antibodies; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; D010455:Peptides